Structural Comparison of AAV9 Derivatives Produced on Two Platforms and Characterization of Their Empty Capsids

被引：0
|
作者：
Placidi, Matteo P. [1 ]
机构：
[1] Voyager Therapeut, TechOps, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
742
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [1] Analytical characterization of full, intermediate, and empty AAV capsids
    Aisleen McColl-Carboni
    Serena Dollive
    Sarah Laughlin
    Rudenc Lushi
    Michael MacArthur
    Shanshan Zhou
    Jeffrey Gagnon
    Christopher A. Smith
    Brenda Burnham
    Robert Horton
    Dimpal Lata
    Brianna Uga
    Kalyani Natu
    Emmanuela Michel
    Celia Slater
    Evan DaSilva
    Robert Bruccoleri
    Tim Kelly
    James B. McGivney
    [J]. Gene Therapy, 2024, 31 : 285 - 294
  • [2] Analytical characterization of full, intermediate, and empty AAV capsids
    McColl-Carboni, Aisleen
    Dollive, Serena
    Laughlin, Sarah
    Lushi, Rudenc
    MacArthur, Michael
    Zhou, Shanshan
    Gagnon, Jeffrey
    Smith, Christopher A.
    Burnham, Brenda
    Horton, Robert
    Lata, Dimpal
    Uga, Brianna
    Natu, Kalyani
    Michel, Emmanuela
    Slater, Celia
    DaSilva, Evan
    Bruccoleri, Robert
    Kelly, Tim
    McGivney, James B.
    [J]. GENE THERAPY, 2024, 31 (5-6) : 285 - 294
  • [3] Differential Histopathological and Proteomics Changes in Dorsal Root Ganglia (DRG) of Cynomolgus Macaques Following Intrathecal (IT) Delivery of "Empty" AAV9 Capsids, and AAV9 Carrying Transcriptionally Active or Inert Cargo
    Guibinga, Ghiabe Henri
    Johnson, Eric W.
    Le, Justin
    Penraat, Kelley
    Hudry, Eloise
    Meseck, Emily
    McElroy, Cameron
    Ozsolak, Fatih
    Mansfield, Keith
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 562 - 563
  • [4] Novel AAV capsids show increased evasion to wild-type AAV9 neutralizing antibodies
    Kerns, S.
    Padegimas, L.
    Miller, T.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A119 - A119
  • [5] Characterization of HSV Derived AAV9 Vectors
    Pechan, Peter
    Golebiowski, Diane
    Seregin, Alexey
    Zapata, Nicole
    Levi, Elise
    Kitsos, Christine
    Lu, Robert
    Amorrortu, Alvaro
    Morris, Carl
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 347 - 347
  • [6] Characterization of AAV Percentage of Full Capsids and Comparability across Platforms
    Ahern, Rachael Maureen
    Drouin, Lauren M.
    Starremans, Patrick G.
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 348 - 349
  • [7] Generation of a randomized heptapeptide library displayed on AAV9 capsids for selection of AAV9-vectors targeted to human endothelium
    Varadi, Karl
    Michelfelder, Stefan
    Trepel, Martin
    Katus, Hugo
    Kleinschmidt, Juergen
    Mueller, Oliver
    [J]. HUMAN GENE THERAPY, 2009, 20 (11) : 1415 - 1415
  • [8] Structural Characterization of H-1 Parvovirus: Comparison of Infectious Virions to Empty Capsids
    Halder, Sujata
    Nam, Hyun-Joo
    Govindasamy, Lakshmanan
    Vogel, Michele
    Dinsart, Christiane
    Salome, Nathalie
    McKenna, Robert
    Agbandje-McKenna, Mavis
    [J]. JOURNAL OF VIROLOGY, 2013, 87 (09) : 5128 - 5140
  • [9] Structure Function Characterization of the ON and OFF State of an AAV9 Provector
    Bennett, Antonette
    Kansol, Austin
    Katircioglu, Stephanie
    Brun, Mitchell
    Fu, Xiaofeng
    Chipman, Paul
    Suh, Junghae
    Agbandje-McKenna, Mavis
    McKenna, Robert
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 243 - 244
  • [10] Single Tyrosine Mutation in AAV8 and AAV9 Capsids Is Insufficient to Enhance Gene Delivery to Skeletal Muscle and Heart
    Qiao, Chunping
    Yuan, Zhenhua
    Li, Jianbin
    Tang, Ruhang
    Li, Juan
    Xiao, Xiao
    [J]. HUMAN GENE THERAPY METHODS, 2012, 23 (01) : 29 - 37
12345